<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Solar Industries India Limited

NSE: SOLARINDS · Lot size: 50

Solar Industries India Limited Open Interest & PCR Analysis

15,084Updated 21 Apr 2026, 01:26 pm IST
PCR
0.75
Bearish signal
Max Pain
13,700
Spot above by ₹1384
Total CE OI
291K
Call writers
Total PE OI
219K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-18

Frequently Asked Questions

What is Solar Industries India Limited PCR (Put-Call Ratio) today?
Solar Industries India Limited's current PCR is 0.75. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Solar Industries India Limited's PCR of 0.75 indicates bearish sentiment.
What is Solar Industries India Limited OI buildup type today?
Solar Industries India Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Solar Industries India Limited?
Solar Industries India Limited has total CE (call) OI of 290850 contracts and total PE (put) OI of 219350 contracts for the nearest expiry. The PCR is 0.75.
How is open interest analysis useful for Solar Industries India Limited trading?
OI analysis for Solar Industries India Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Solar Industries India Limited?
Solar Industries India Limited's max pain is ₹13,700 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.